NCT07725432: Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation
- State
- Under way
- Phase
- Phase 2
- People
- 34 planned
- Started
- 25 Jul 2024
- Primary completion
- 7 Jul 2026
- Arms
- Topical ruxolitinib
- Results
- None posted
- 25 Jul 2024: Trial started
- 24 Jul 2026: Trial registered